Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Static Stretching on Postural Sway and Plantar Pressures

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03743168
Recruitment Status : Completed
First Posted : November 16, 2018
Last Update Posted : November 16, 2018
Sponsor:
Information provided by (Responsible Party):
César Calvo Lobo, Universidad de León

Brief Summary:
Risk for falls has been associated with falls efficacy and postural balance. The objective was to compare the effects on the footprint and the stabilometry of the continuous stretch and the intermittent. Subjects were randomly assigned to an intermittent stretching protocol group or continuous stretch group both of them loading passive plantar flexor stretching. Static footprint and stabilometry were measured before and after both protocols.

Condition or disease Intervention/treatment Phase
Muscle Stretching Exercise; Postural Balance; Stabilometry; Platform Other: Intermittent stretching protocol Other: Continuous stretch Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 48 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Acute Effects of Intermittent Versus Continuous Bilateral Ankle Plantar Flexors Static Stretching on Postural Sway and Plantar Pressures During Standing
Actual Study Start Date : September 1, 2018
Actual Primary Completion Date : October 1, 2018
Actual Study Completion Date : October 15, 2018

Arm Intervention/treatment
Experimental: Intermittent stretching protocol
Intermittent stretching protocol including five sets at 1 minute and 15 second rest.
Other: Intermittent stretching protocol
Intermittent stretching protocol of five sets of 1 minute and15 second rest

Experimental: Continuous stretch
2 minutes continuous stretch
Other: Continuous stretch
2 minutes continuous stretch




Primary Outcome Measures :
  1. Foot plantar pressure [ Time Frame: Change from foot plantar pressure at 2 minutes ]
    Maximum foot plantar pressure measured as K Pa



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Non-trained individuals
  • Healthy subjects

Exclusion Criteria:

  • Previous surgery on the lower extremities
  • Injuries
  • Musculoskeletal conditions

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03743168


Locations
Layout table for location information
Spain
Ricardo Becerro de Bengoa Vallejo
Madrid, Spain, 28040
Sponsors and Collaborators
Universidad de León
Layout table for additonal information
Responsible Party: César Calvo Lobo, Principal Investigator, Universidad de León
ClinicalTrials.gov Identifier: NCT03743168    
Other Study ID Numbers: Static-Stretching
First Posted: November 16, 2018    Key Record Dates
Last Update Posted: November 16, 2018
Last Verified: November 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No